{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T18:30:19Z","timestamp":1793557819610,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006402","name":"Fasa University of Medical Science","doi-asserted-by":"publisher","award":["400287"],"award-info":[{"award-number":["400287"]}],"id":[{"id":"10.13039\/501100006402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e36767","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:02:44Z","timestamp":1724392964000},"page":"e36767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histological assessment for investigation of dose-dependent ovarian toxicity of cyclophosphamide in the rat"],"prefix":"10.1016","volume":"10","author":[{"given":"Narges","family":"Elahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ebrahim","family":"Astaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Makoolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e36767_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-018-0409-9","article-title":"Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model","volume":"11","author":"Melekoglu","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02292-y","article-title":"Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study","volume":"22","author":"Sharma","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e36767_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5760011","article-title":"A review on treatment of premature ovarian insufficiency: characteristics, limitations, and challenges of stem cell versus ExosomeTherapy","volume":"2023","author":"Elahi","year":"2023","journal-title":"Vet. Med. Int."},{"key":"10.1016\/j.heliyon.2024.e36767_bib5","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S242703","article-title":"The protective effect of testosterone on the ovarian reserve during cyclophosphamide treatment","volume":"13","author":"Yoo","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.heliyon.2024.e36767_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/0960327119865588","article-title":"Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice","volume":"38","author":"Elkady","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib7","doi-asserted-by":"crossref","DOI":"10.1590\/s0102-865020180060000004","article-title":"The therapeutic effects of curcumin and capsaicin against cyclophosphamide side effects on the uterus in rats","volume":"33","author":"Yilmaz","year":"2018","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.heliyon.2024.e36767_bib8","article-title":"Moxibustion against cyclophosphamide-induced premature ovarian failure in rats through inhibiting NLRP3-\/caspase-1-\/GSDMD-dependent pyroptosis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evidence-Based Complement. Altern. Med."},{"key":"10.1016\/j.heliyon.2024.e36767_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28611-2","article-title":"TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice","volume":"13","author":"Qin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e36767_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s43032-021-00499-1","article-title":"Human umbilical cord mesenchymal stem cells improve ovarian function in chemotherapy-induced premature ovarian failure mice through inhibiting apoptosis and inflammation via a paracrine mechanism","volume":"28","author":"Deng","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.heliyon.2024.e36767_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-020-04010-3","article-title":"Effect of the drug cyclophosphamide on the activity of porcine kidney betaine aldehyde dehydrogenase","volume":"476","author":"Cruz-Valencia","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e36767_bib12","article-title":"Methanolic Extract of Curcuma caesia Roxb. prevents the toxicity caused by Cyclophosphamide to bone marrow cells, liver and kidney of mice","volume":"8","author":"Devi","year":"2016","journal-title":"Pharmacogn. Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11356-019-05915-3","article-title":"The effects of naringin on different cyclophosphamide-induced organ toxicities in rats: investigation of changes in some metabolic enzyme activities","volume":"26","author":"Caglayan","year":"2019","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.heliyon.2024.e36767_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \"burnout \"; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e36767_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/09553002.2021.1919782","article-title":"Preliminary pre-clinical studies on the side effects of breast cancer treatment","volume":"97","author":"Salata","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111889","article-title":"Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis","volume":"211","author":"Zhang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.heliyon.2024.e36767_bib19","article-title":"The pathological features of cyclophosphamide induced multi-organs toxicity in male wister rats","volume":"11","author":"Al-Salih","year":"2020","journal-title":"Sys. Rev. Pharm."},{"key":"10.1016\/j.heliyon.2024.e36767_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6539294","article-title":"Umbilical cord mesenchymal stem cell transplantation prevents chemotherapy-induced ovarian failure via the NGF\/TrkA pathway in rats","volume":"2019","author":"Zheng","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e36767_bib21","article-title":"Effect of transplantation of bone marrow stromal cell-conditioned medium on ovarian function, morphology and cell death in cyclophosphamide-treated rats","volume":"20","author":"Khanmohammadi","year":"2018","journal-title":"Cell J"},{"key":"10.1016\/j.heliyon.2024.e36767_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121536","article-title":"Regenerative potential of different extracellular vesicle subpopulations derived from clonal mesenchymal stem cells in a mouse model of chemotherapy-induced premature ovarian failure","author":"Eslami","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e36767_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3695848","article-title":"Human amniotic fluid mesenchymal stem cell-derived exosomes inhibit apoptosis in ovarian granulosa cell via miR-369-3p\/YAF2\/PDCD5\/p53 pathway","volume":"2022","author":"Geng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2024.e36767_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-018-9867-0","article-title":"Human menstrual blood-derived stromal cells promote recovery of premature ovarian insufficiency via regulating the ECM-dependent FAK\/AKT signaling","volume":"15","author":"Feng","year":"2019","journal-title":"Stem Cell Rev. Reports"},{"key":"10.1016\/j.heliyon.2024.e36767_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1490-8","article-title":"Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1","volume":"10","author":"Huang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e36767_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-018-0953-7","article-title":"Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD","volume":"9","author":"Huang","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e36767_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-023-01214-1","article-title":"Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-\u03b2\/Smads signaling pathway","volume":"16","author":"Nazdikbin Yamchi","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib28","article-title":"Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model","volume":"2016","author":"Li","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e36767_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7827-1-11","article-title":"Ovarian follicle counts - not as simple as 1, 2, 3","volume":"1","author":"Tilly","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36767_bib31","first-page":"951","article-title":"Junqueira's basic histology _ text and atlas","volume":"6","author":"Rachman","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.heliyon.2024.e36767_bib32","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2024.e36767_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.humrep.a137985","article-title":"Infertility: ultrastructure of human ovarian primordial follicles after combination chemotherapy for hodgkin's disease","volume":"8","author":"Familiari","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.heliyon.2024.e36767_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.1978.166","article-title":"Morphological study of the ovaries of leukaemic children","volume":"38","author":"Himelstein-Braw","year":"1978","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e36767_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e36767_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Emiliano Maiani","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e36767_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-020-00735-3","article-title":"Chemoprotective effects of plasma derived from mice of different ages and genders on ovarian failure after cyclophosphamide treatment","volume":"13","author":"Bahmanpour","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib39","first-page":"10","article-title":"Zarbakhsh, effect of transplantation of bone marrow stromal cell conditioned medium on ovarian function, morphology and cell death in cyclophosphamide-treated rats","volume":"20","author":"Khanmohammadi","year":"2018","journal-title":"Cell J"},{"key":"10.1016\/j.heliyon.2024.e36767_bib40","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2004.10.011","article-title":"Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level","volume":"83","author":"Hendriks","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2024.e36767_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(03)00664-2","article-title":"A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles","volume":"80","author":"Frattarelli","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2024.e36767_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/15376516.2018.1491662","article-title":"Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: a stereological study","volume":"28","author":"Dehghani","year":"2018","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.heliyon.2024.e36767_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-020-00763-z","article-title":"Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments","volume":"14","author":"Li","year":"2021","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.heliyon.2024.e36767_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.heliyon.2024.e36767_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-020-01975-2","article-title":"The protective effect of fenofibrate, triptorelin, and their combination against premature ovarian failure in rats","volume":"394","author":"Abdelzaher","year":"2021","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e36767_bib47","doi-asserted-by":"crossref","DOI":"10.21608\/bvmj.2020.28289.1200","article-title":"Curcumin and Hesperidin alleviates oxidative stress and hormonal alterations in a rat model of cyclophosphamide-induced premature ovarian failure","volume":"39","author":"Elnahas","year":"2020","journal-title":"Benha Vet. Med. J."},{"key":"10.1016\/j.heliyon.2024.e36767_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e36767_bib49","doi-asserted-by":"crossref","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-mullerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024127983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024127983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:11:20Z","timestamp":1790543480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024127983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024127983"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36767","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histological assessment for investigation of dose-dependent ovarian toxicity of cyclophosphamide in the rat","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36767"}}